Oluchi Ekenze

Dr. Oluchi Ekenze

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Hypertension
Verified
Journal Article
Closed access
RPRodica E. Petrea
Rodica E. Petrea
APAdlin Pinheiro
Adlin Pinheiro
SDSerkalem Demissie
Serkalem Demissie
OEOluchi Ekenze
Oluchi Ekenze
HAHugo J. Aparicio
Hugo J. Aparicio
JRJose Romero
Jose Romero
BACKGROUND: Hypertension is the most potent stroke risk factor and is also related to cerebral small vessel disease. We studied the relation between mid-to-late-life hypertension trends and cerebral white matter injury in community-dwelling individuals from the FHS (Framingham Heart Study). METHODS: FHS Offspring cohort participants with available mid-life and late-life blood pressure measurements and brain magnetic resonance imaging were included. Multiple regression analyses were used to relate hypertension trends (normotension-normotension [reference], normotension-hypertension, and hypertension-hypertension) to white matter injury metrics on diffusion tensor imaging (free water, fractional anisotropy, and peak skeletonized mean diffusivity) and Fluid Attenuated Inversion Recovery (white matter hyperintensity volume) by different blood pressure cutoffs (130/80, 140/90, and 150/90 mm Hg). RESULTS: We included 1018 participants (mean age 47.3±7.4 years at mid-life and 73.2±7.3 at late-life). At the 140/90 mm Hg cutoff, the hypertension-hypertension trend was associated with higher free water (β, 0.16 [95% CI, 0.03–0.30]; P =0.021) and peak skeletonized mean diffusivity (β, 0.15 [95% CI, 0.01–0.29]; P =0.033). At a 130/80 mm Hg cutoff, the hypertension-hypertension trend had significantly higher free water (β, 0.16 [95% CI, 0.01–0.30]; P =0.035); and the normotension-hypertension (β, 0.24 [95% CI, 0.03–0.44]; P =0.027) and hypertension-hypertension (β, 0.22 [95% CI, 0.04–0.41]; P =0.022) trends had significantly increased white matter hyperintensity volume. Exploratory stratified analysis showed effect modifications by APOE ɛ4 allele and age. CONCLUSIONS: Mid-to-late-life hypertension exposure is significantly associated with microstructural and to a lesser extent, visible white matter injury; the effects are observed at both conventional and lower blood pressure cutoffs and are associated with longer duration of hypertension.

14 September 2023 in Brain Sciences
Verified
Journal Article
Open access
PDF file
FLFrances Rodriguez Lara
Frances Rodriguez Lara
ATArturo Ruben Toro
Arturo Ruben Toro
APAdlin Pinheiro
Adlin Pinheiro
SDSerkalem Demissie
Serkalem Demissie
OEOluchi Ekenze
Oluchi Ekenze
JRJose Romero
Jose Romero
Perivascular spaces (PVS) visible on brain MRI signal cerebral small vessel disease (CSVD). The coexistence of PVS with other CSVD manifestations likely increases the risk of adverse neurological outcomes. We related PVS to other CSVD manifestations and brain volumes that are markers of vascular brain injury and neurodegeneration. Framingham Heart Study (FHS) participants with CSVD ratings on brain MRI were included. PVS were rated in the basal ganglia (BG) and centrum semiovale (CSO) into grades I–IV and a category reflecting high burden in single or mixed CSO-BG regions. We related PVS to covert brain infarcts (CBI), white matter hyperintensities (WMH), cerebral microbleeds (CMB), total brain, hippocampal, and cortical gray matter volumes using adjusted multivariable regression analyses. In 2454 participants (mean age 54 ± 12 years), we observed that higher PVS burden in both BG and CSO was related to CMB in lobar and deep brain regions and increased WMH. Greater CSO PVS burden was associated with decreased total cortical gray volumes. PVS are associated with ischemic markers of CSVD and neurodegeneration markers. Further studies should elucidate the causality between PVS and other CSVD manifestations.

7 October 2025 in Neurology
Verified
Journal Article
Open access
APAdlin Pinheiro
Adlin Pinheiro
OEOluchi Ekenze
Oluchi Ekenze
HAHugo Aparicio
Hugo Aparicio
ABAlexa S. Beiser
Alexa S. Beiser
CDCharles DeCarli
Charles DeCarli
JRJose Romero
Jose Romero
Individual MRI markers of cerebral small vessel disease (CSVD) are associated with impaired cognition and dementia but may not reflect the overall burden of CSVD. In addition, it is unclear whether these markers provide additional value in dementia risk assessment beyond vascular risk factors alone. Thus, we studied the association between the additive burden of multiple CSVD markers and incident dementia and determined whether this relationship remains independent of the Framingham Stroke Risk Profile (FSRP), a tool used commonly used for stroke risk prediction. A total of 1,152 MRI scans from participants in the Original and Offspring cohorts of the Framingham Heart Study, a large observational cohort study, were included. Participants were older than 55 years and free of prevalent dementia, stroke, or other neurologic conditions at the time of MRI. A multimarker score capturing CSVD burden was defined as the sum of CSVD features detected in the MRI: cerebral microbleeds, covert brain infarcts, extensive white matter hyperintensities, high-burden perivascular spaces, and cortical superficial siderosis. Multivariate Cox regression models examined the association between the multimarker CSVD score and incident all-cause dementia, Alzheimer dementia (AD), and vascular dementia. The mean age was 70.9 years (SD 8.7) (527 [46%] were male), and 211 (18%) had a CSVD score of ≥2. Over a median follow-up time of 7.4 years (interquartile range 4.6-11.3), participants with a score ≥2 had significantly elevated risk of all-cause dementia compared with those with no CSVD markers after adjustment for the FSRP (hazard ratio [HR] 1.67; 95% CI 1.05-2.66) and vascular risk factors (HR 1.76; 95% CI 1.10-2.81). The multimarker CSVD score demonstrated similar model performance metrics to the FSRP (Harrell c-statistics 0.82-0.83). We found a significant association between all-cause dementia and multimarker CSVD scores, which was independent of the FSRP as well as its individual components. Our results support the use of a multimarker CSVD score as an indicator for incident all-cause dementia risk and suggest that it may be as robust as the FSRP. Further studies are necessary to validate the use of a multimarker CSVD score in dementia risk prediction.

18 November 2025 in Journal of the American Heart Association
Verified
Journal Article
Open access
APAdlin Pinheiro
Adlin Pinheiro
HAHugo Aparicio
Hugo Aparicio
VLVasileios-Arsenios Lioutas
Vasileios-Arsenios Lioutas
ABAlexa Beiser
Alexa Beiser
OEOluchi Ekenze
Oluchi Ekenze
JRJose Romero
Jose Romero
Background: Mild manifestations of individual cerebral small vessel disease (CSVD) markers are common and may not denote increased risk, but high CSVD burden identifies individuals at increased risk of stroke and dementia. Scores incorporating multiple individual CSVD markers may better identify a person’s risk. We related a multimarker CSVD score to risk of incident stroke and compared it with the Framingham Stroke Risk Profile (FSRP) in community‐dwelling individuals. Methods: Framingham Heart Study participants aged ≥55 years, free of stroke and dementia, and with brain magnetic resonance imaging ratings of CSVD markers were included. A multimarker CSVD score reflecting increasing CSVD burden was used, assigning 1 point each for presence of cerebral microbleeds, severe perivascular spaces, extensive white matter hyperintensities, covert brain infarcts, and cortical superficial siderosis. Multivariable Cox proportional hazards regression analyses were used to relate CSVD score to incident stroke. Results: Among 1154 participants (46% men, mean age 70.9±8.7 years), 92 (8%) developed stroke over a median follow‐up of 8.6 years (Q1–Q3: 5.1–12.5). In models adjusting for age, sex, time interval between clinic exam and magnetic resonance imaging, Framingham cohort, and FSRP, those with ≥3 markers had increased risk of stroke (hazard ratio [HR], 2.62 [95% CI, 1.17–5.88]). In comparison, a 5% increase in FSRP was also associated with increased risk (adjusted HR, 1.16 [95% CI, 1.04–1.29]). The FSRP and CSVD score had similar model discrimination metrics. Conclusions: Higher CSVD burden is associated with increased risk of stroke, beyond the effect explained by risk factors in the FSRP. These findings support consideration of CSVD burden to identify risk of stroke in community‐dwelling individuals for early implementation of preventive strategies.

27 February 2025 in Neurobiology of Aging
Verified
Journal Article
Closed access
OEOluchi Ekenze
Oluchi Ekenze
SSStephan Seiler
Stephan Seiler
APAdlin Pinheiro
Adlin Pinheiro
CDCharles DeCarli
Charles DeCarli
PPPedram Parva
Pedram Parva
JRJose Romero
Jose Romero

29 July 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
OEOluchi Ekenze
Oluchi Ekenze
APAdlin Pinheiro
Adlin Pinheiro
ABAlexa S. Beiser
Alexa S. Beiser
VLVasileios-Arsenios Lioutas
Vasileios-Arsenios Lioutas
HAHugo Aparicio
Hugo Aparicio
JRJose Romero
Jose Romero
Background/Objectives: Cardiovascular disease (CVD) contributes to stroke and dementia. Individuals with CVD have high risk for adverse cognitive outcomes and stroke, possibly due to shared risk factors between CVD, stroke, and dementia, which may be attributed to cerebral small vessel disease (CSVD). We aim to determine the association between prevalent CVD and atrial fibrillation (AF) with CSVD. Methods: Composite of CVD [coronary heart disease, heart failure (HF)], its individual components, and AF were assessed. Multi-marker CSVD score was used to reflect increasing CSVD burden (cerebral microbleeds (CMBs), high-burden perivascular spaces, extensive white matter hyperintensity, cortical superficial siderosis, or covert brain infarcts were assigned 1 point each, with a range of 0–5). We related prevalent CVD, its individual components, and AF to multi-marker CSVD score and individual CSVD markers using logistic regression analyses adjusted for age, sex, FHS cohort, time between MRI and clinic exam (model-1), and vascular risk factors (model-2). Results: In 3413 participants (mean age: 59 ± 14 years, 53.4% women), 11% had prevalent CVD or AF, 8% had prevalent CVD, and 4% had prevalent AF. One CSVD marker was seen in 23% participants, and 9% had ≥ 2 markers. In multivariable-adjusted analyses, composite prevalent CVD and AF was associated with the presence of one CSVD marker (OR: 1.38, 95% confidence interval [CI]: 1.05–1.84). The association with ≥2 CSVD markers was not significant. Only CMBs were associated with components of CVD and AF, with the highest odds of association with HF. Conclusions: Prevalent CVD (including AF) is associated with the presence of CSVD, with all components associated with CMBs.